Case Summary:

With a Ph.D. in Pharmacy, an instructor exhibited the ability to further his research in the pharmacology field. When our client engaged our law firm’s services to help him in filing an I-140 NIW (National Interest Waiver) petition, we started evaluating his strong academic background which has laid the foundation for his current position and proved the veracity of his credentials. After reviewing his research summary focusing on the development of immune-based therapies for conditions such as Alzheimer’s disease in pharmacology, addressing some of our nation’s and the world’s most pressing issues, including understanding how to improve neuroprotective treatments for diseases like Alzheimer’s and Parkinson’s. Also, he has achieved a consistent and notable record of success and influence in this area of study.

We noted that his research is of great interest to the scientific community, but it is also relevant to global public health, thus we started preparing a strong case on his behalf by combining the following important points in his petition packet:

We noted our client’s publications on the development of immune-based therapies for conditions such as Alzheimer’s disease is cited a total of 531 times from the 27 peer-reviewed scientific articles (10 of them first-authored), which were published in leading journals, widely cited by other independent experts, and secured international funding such as from the National Institutes of Health (NIH) and the Department of Defense (DoD). The NIH aims to improve public health and longevity in the United States, while the DoD works to improve the national security of the United States. This confirms the immediate worth of his work in global efforts to develop effective treatments for heavy health burdens, including Alzheimer’s disease.

Besides, the field has recognized his authority by inviting him to review and evaluate the work of his peers no fewer than 38 times. Since only the most highly esteemed researchers in the field are invited to evaluate the work of their peers, especially in dogmatic journals, it authenticates that he is seen as very qualified in the field.

Going ahead, we added his employment letter confirming her current position and a signed statement from him describing his future research plans along with four recommendation letters acquired by his fellow researchers to reinforce his case. One of whom shared the following statement:

“In summary, [client] is an incredibly original researcher whose contributions to his field and anti-obesity drug development distinguish him from his peers. His work is of unparalleled value for the United States and the scholarly community in general, and it must be allowed to continue unimpeded.”

Successfully, USCIS was convinced that our client is a leading pharmacologist who has made substantive strides in the development of anti-obesity agents, and by extension, his research is of direct consequence for U.S. health and economics. He was granted his NIW petition approval within 7 months, and that too without raising any further request for evidence. We thank our diligent team and our client for choosing us to draft his I-140 application. We wish him well in his future endeavors.